Change in biopharma outsourcing model usage 2021 vs. 2023

Published by
Matej Mikulic,
Sep 25, 2023
According to a survey conducted in 2023, over 40 percent of surveyed biopharma executives stated that the usage of the functional service provider (FSP) outsourcing model has increased compared to two years ago. This statistic describes the change in full-service and FSP outsourcing models among biopharmaceutical companies worldwide in 2021-2023.

Change in usage of full-service and FSP outsourcing models among biopharmaceutical companies worldwide in 2021-2023

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

September 2023

Region

Worldwide

Survey time period

March and April 2023

Number of respondents

150 executives

Special properties

respondents from large companies: n=65, from small/mid: n=85

Method of interview

Panel survey

Supplementary notes

The respondents are working for pharma, biopharma, or biotech companies; they have drug development decision-making responsibility and are director-level or above; they work in a role related to drug development; their companies have at least one compound in development; they are from the US/Canada, Europe, and Asia.

Original question: "Over the past two years, how has your company changed its full-service clinical trial outsourcing behavior?"
"Over the past two years, how has your company changed its functional service provider (FSP) outsourcing behavior?"

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Outsourcing in the pharmaceutical industry "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Outsourcing in the pharmaceutical industry

Overview

5

CROs

4

CDMOs/CMOs

5

CDMO deals

5

Trends

4

Further Content: You might find this interesting as well

Topics

Outsourcing in the pharmaceutical industryGlobal pharmaceutical industryBiotech drugsPharmaceutical industry in the U.S.Top pharmaceutical drugs
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu